PMID: 7545877Jan 1, 1995Paper

In pursuit of the "holy grail": recombinant allergens and peptides as catalysts for the allergen-specific immunotherapy

Allergy
S MohapatraD Salo

Abstract

This presentation reviews recent progress in knowledge of (i) molecular biology and immunology of allergens and (ii) the methods for the modulation of allergen-specific immune response, with special emphasis on our grass pollen allergens, particularly Pao p IX AL, used as a model. The last few years have seen tremendous progress in molecular characterization of allergens, leading to synthesis of a number of recombinant allergens. Furthermore, studies of the structure-activity relationship of allergens have led to the delineation of the epitopes of these allergens and of widespread cross-reactivities among diverse allergens. In view of the requirement for extensive pre-clinical studies, the application of the recombinant allergens and epitopes in the clinical realm has just begun. Studies in murine systems suggest that these allergens and/or their epitopic peptides downregulate allergen-specific immune responses de novo. The potential and drawbacks of the recombinant allergens and peptides for improving the existing immunotherapeutic approaches and for developing new approaches to specific immunotherapy are discussed.

References

Nov 1, 1992·Molecular Immunology·L ZhangS S Mohapatra
Jan 1, 1992·International Archives of Allergy and Immunology·E Olsen, S S Mohapatra
Oct 1, 1992·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J Bousquet, F B Michel
Apr 1, 1992·Journal of Autoimmunity·A A VandenbarkH Offner
Jan 1, 1992·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·N Arora, S V Gangal
Apr 1, 1992·The Journal of Allergy and Clinical Immunology·S S Mohapatra
Jan 1, 1992·International Archives of Allergy and Immunology·R ValentaO Scheiner
Jan 1, 1991·International Archives of Allergy and Applied Immunology·L ZhangS S Mohapatra
Jan 1, 1992·The Journal of Allergy and Clinical Immunology·K Y ChuaI G Macreadie
Jul 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A LitwinJ G Michael
Jun 1, 1991·The Journal of Allergy and Clinical Immunology·M YangS S Mohapatra
Nov 1, 1990·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J G MichaelA Pesce
Apr 1, 1989·Current Opinion in Immunology·R G Hamilton
Jan 1, 1987·International Archives of Allergy and Applied Immunology·A W WheelerD M Moran
Jan 1, 1987·International Archives of Allergy and Applied Immunology·A W WheelerD M Moran
Dec 1, 1994·Immunology Today·S S Mohapatra
Jan 1, 1993·International Archives of Allergy and Immunology·C SuphiogluR B Knox
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T J BrinerJ L Greenstein
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·L R WedderburnM J Owen
Mar 5, 1993·Science·S L ReinerR M Locksley
Jan 1, 1993·Archives of Insect Biochemistry and Physiology·M D TomalskiL K Miller
Jan 1, 1993·Annual Review of Immunology·F W FitchT F Gajewski
May 14, 1993·Science·A Lanzavecchia

❮ Previous
Next ❯

Citations

Oct 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S McHugh
Aug 7, 2003·Expert Review of Vaccines·Prem L Bhalla
Mar 29, 2014·Circulation Research·Adili RehemanHeyu Ni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.